無血清培地市場(培地タイプ。CHO細胞培地、タンパク質発現培地、免疫培地、昆虫細胞培地、ハイブリドーマ培地、幹細胞培地、化学修飾培地)、エンドユーザー。バイオファーマ産業、臨床研究機関、研究センター、その他) - 世界の産業分析、サイズ、シェア、成長、傾向、予測、2021-2031年Serum-free Media Market (Media Type: CHO Cell Media, Protein Expression Media, Immunology Media, Insect Cell Media, Hybridoma Media, Stem Cell Media, and Chemically-defined Media; and End-user: Biopharma Industry, Clinical Research Organizations, Research Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 無血清培地市場 - レポートの範囲 TMRの調査レポート「世界の無血清培地市場」は、2021年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会に... もっと見る
サマリー無血清培地市場 - レポートの範囲TMRの調査レポート「世界の無血清培地市場」は、2021年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2020年を基準年、2031年を予測年として、2017年から2031年までの無血清培地の世界市場の売上を掲載しています。また、2021年から2031年までの無血清培地の世界市場の複合年間成長率(CAGR %)を記載しています。 本レポートは、広範な一次および二次調査を経て作成された。一次調査では、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施し、調査作業の大部分を行った。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、世界の無血清培地市場を理解しました。 二次調査には、インターネット上の情報源、政府機関の統計データ、ウェブサイト、業界団体も含まれます。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、世界の無血清培地市場の様々な属性を調査しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長挙動に関するスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、世界の無血清培地市場における競争力学の変化に光を当てています。これらは、既存の市場参加者だけでなく、世界の無血清培地市場への参入に関心を持つ事業者にとっても貴重なツールとなります。 本レポートでは、世界の無血清培地市場の競争環境について掘り下げています。世界の無血清培地市場で活動する主要企業を特定し、それぞれの企業を様々な属性でプロファイリングしています。会社概要、財務状況、最近の開発、SWOTは、本レポートで紹介されている世界の無血清培地市場のプレイヤーの属性です。 無血清培地の世界市場レポートで回答した主要な質問 予測期間中の全地域における無血清培地市場の売上/収入はどの程度か? 世界の無血清培地市場におけるビジネスチャンスは何か? 市場における主要なドライバー、阻害要因、機会、脅威は何か? 予測期間中に最も速いCAGRで拡大すると思われる地域市場はどこか? 2031年に世界で最も高い収益を上げると予想される製品セグメントは?予測期間中に最も高いCAGRで拡大すると予測されるのはどのセグメントか? 世界市場で事業を展開する各企業の市場での位置づけはどのようなものか? 無血清培地市場 - 調査目的と調査アプローチ 無血清培地の世界市場に関する包括的なレポートは、まず概要から始まり、次に調査範囲と目的について説明します。本調査の目的、市場で活動する主要ベンダーと流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。 読みやすさを考慮し、章立てのレイアウトでまとめ、各セクションを細かく分割しています。また、グラフや表が適切に配置され、網羅的な構成となっています。主要セグメントの実績値および予測値を図式化し、読者に視覚的に訴える。また、過去と予測期間終了時の主要セグメントの市場シェアの比較も可能です。 本レポートでは、世界の無血清培地市場を培地タイプ、エンドユーザー、地域の観点から分析しています。各基準における主要セグメントを詳細に調査し、2030年末の各市場シェアを掲載しています。このような貴重な洞察は、市場関係者が世界の無血清培地市場への投資について十分な情報を得た上でビジネス上の意思決定を行うことを可能にします。 目次1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Serum-free Media Market 4. Market Overview 4.1. Introduction 4.1.1. Media type Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Serum-free Media Market Analysis and Forecast, 2018–2030 4.4.1. Market Revenue Projections (US$ Mn) 4.4.2. Market Volume/Unit Shipments Projections 5. Key Insights 5.1. Key Product/brand Analysis 5.2. Applications of different Serum-free Media’s in Cell culture 5.3. COVID-19 Pandemic Impact on Serum-free Media Market 6. Global Serum-free Media Market Analysis and Forecast, by Media Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Media Type, 2017-2031 6.3.1. CHO Cell Media 6.3.2. Protein Expression Media 6.3.3. Immunology Media 6.3.4. Insect Cell Media 6.3.5. Hybridoma Media 6.3.6. Stem Cell Media 6.3.7. Chemically-defined Media 6.4. Market Attractiveness Analysis, by Media Type 7. Global Serum-free Media Market Analysis and Forecasts, By End-user 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by End-user, 2017–2031 7.3.1. Biopharma Industry 7.3.2. Clinical Research Organizations 7.3.3. Research Centers 7.3.4. Others 7.4. Market Attractiveness Analysis, by End-user 8. Global Serum-free Media Market Analysis and Forecasts, By Region 8.1. Key Findings 8.2. Market Value Forecast, by Region 8.2.1. North America 8.2.2. Europe 8.2.3. Asia Pacific 8.2.4. Latin America 8.2.5. Middle East & Africa 8.3. Market Attractiveness Analysis, by Region 9. North America Serum-free Media Market Analysis and Forecast 9.1. Introduction 9.1.1. Key Findings 9.2. Market Value Forecast, by Media Type, 2017–2031 9.2.1. CHO Cell Media 9.2.2. Protein Expression Media 9.2.3. Immunology Media 9.2.4. Insect Cell Media 9.2.5. Hybridoma Media 9.2.6. Stem Cell Media 9.2.7. Chemically-defined Media 9.3. Market Value Forecast, by End-user, 2017–2031 9.3.1. Biopharma Industry 9.3.2. Clinical Research Organizations 9.3.3. Research Centers 9.3.4. Others 9.4. Market Value Forecast, by Country, 2017–2031 9.4.1. U.S. 9.4.2. Canada 9.5. Market Attractiveness Analysis 9.5.1. By Media Type 9.5.2. By End-user 9.5.3. By Country 10. Europe Serum-free Media Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Media Type, 2017–2031 10.2.1. CHO Cell Media 10.2.2. Protein Expression Media 10.2.3. Immunology Media 10.2.4. Insect Cell Media 10.2.5. Hybridoma Media 10.2.6. Stem Cell Media 10.2.7. Chemically-defined Media 10.3. Market Value Forecast, by End-user, 2017–2031 10.3.1. Biopharma Industry 10.3.2. Clinical Research Organizations 10.3.3. Research Centers 10.3.4. Others 10.4. Market Value Forecast, by Country/Sub-region, 2017–2031 10.4.1. Germany 10.4.2. U.K. 10.4.3. France 10.4.4. Spain 10.4.5. Italy 10.4.6. Rest of Europe 10.5. Market Attractiveness Analysis 10.5.1. By Media Type 10.5.2. By End-user 10.5.3. By Country/Sub-region 11. Asia Pacific Serum-free Media Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Media Type, 2017–2031 11.2.1. CHO Cell Media 11.2.2. Protein Expression Media 11.2.3. Immunology Media 11.2.4. Insect Cell Media 11.2.5. Hybridoma Media 11.2.6. Stem Cell Media 11.2.7. Chemically-defined Media 11.3. Market Value Forecast, by End-user, 2017–2031 11.3.1. Biopharma Industry 11.3.2. Clinical Research Organizations 11.3.3. Research Centers 11.3.4. Others 11.4. Market Value Forecast, by Country/Sub-region, 2017–2031 11.4.1. China 11.4.2. Japan 11.4.3. India 11.4.4. Australia & New Zealand 11.4.5. Rest of Asia Pacific 11.5. Market Attractiveness Analysis 11.5.1. By Media Type 11.5.2. By End-user 11.5.3. By Country/Sub-region 12. Latin America Serum-free Media Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Media Type, 2017–2031 12.2.1. CHO Cell Media 12.2.2. Protein Expression Media 12.2.3. Immunology Media 12.2.4. Insect Cell Media 12.2.5. Hybridoma Media 12.2.6. Stem Cell Media 12.2.7. Chemically-defined Media 12.3. Market Value Forecast, by End-user, 2017–2031 12.3.1. Biopharma Industry 12.3.2. Clinical Research Organizations 12.3.3. Research Centers 12.3.4. Others 12.4. Market Value Forecast, by Country/Sub-region, 2017–2031 12.4.1. Brazil 12.4.2. Mexico 12.4.3. Rest of Latin America 12.5. Market Attractiveness Analysis 12.5.1. By Media Type 12.5.2. By End-user 12.5.3. By Country/Sub-region 13. Middle East & Africa Serum-free Media Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Media Type, 2017–2031 13.2.1. CHO Cell Media 13.2.2. Protein Expression Media 13.2.3. Immunology Media 13.2.4. Insect Cell Media 13.2.5. Hybridoma Media 13.2.6. Stem Cell Media 13.2.7. Chemically-defined Media 13.3. Market Value Forecast, by End-user, 2017–2031 13.3.1. Biopharma Industry 13.3.2. Clinical Research Organizations 13.3.3. Research Centers 13.3.4. Others 13.4. Market Value Forecast, by Country/Sub-region, 2017–2031 13.4.1. GCC Countries 13.4.2. South Africa 13.4.3. Rest of Middle East & Africa 13.5. Market Attractiveness Analysis 13.5.1. By Media Type 13.5.2. By End-user 13.5.3. By Country/Sub-region 14. Competition Landscape 14.1. Market Player – Competition Matrix (By Tier and Size of companies) 14.2. Market Share Analysis by Company (2020) 14.3. Company Profiles 14.3.1. Thermo Fisher Scientific 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.1.2. Product Portfolio 14.3.1.3. SWOT Analysis 14.3.1.4. Strategic Overview 14.3.2. Athena Environmental Sciences 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2.2. Product Portfolio 14.3.2.3. SWOT Analysis 14.3.2.4. Strategic Overview 14.3.3. Pan Biotech 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.3.2. Product Portfolio 14.3.3.3. SWOT Analysis 14.3.3.4. Strategic Overview 14.3.4. Sigma-Aldrich 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.4.2. Product Portfolio 14.3.4.3. SWOT Analysis 14.3.4.4. Strategic Overview 14.3.5. CellGenix 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.5.2. Product Portfolio 14.3.5.3. SWOT Analysis 14.3.5.4. Strategic Overview 14.3.6. HiMedia Laboratories 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.6.2. Product Portfolio 14.3.6.3. SWOT Analysis 14.3.6.4. Strategic Overview 14.3.7. Biological Industries 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.7.2. Product Portfolio 14.3.7.3. SWOT Analysis 14.3.7.4. Strategic Overview 14.3.8. Irvine Scientific 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.8.2. Product Portfolio 14.3.8.3. SWOT Analysis 14.3.8.4. Strategic Overview
SummarySerum-free Media Market – Scope of Report Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Serum-free Media Market 4. Market Overview 4.1. Introduction 4.1.1. Media type Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Serum-free Media Market Analysis and Forecast, 2018–2030 4.4.1. Market Revenue Projections (US$ Mn) 4.4.2. Market Volume/Unit Shipments Projections 5. Key Insights 5.1. Key Product/brand Analysis 5.2. Applications of different Serum-free Media’s in Cell culture 5.3. COVID-19 Pandemic Impact on Serum-free Media Market 6. Global Serum-free Media Market Analysis and Forecast, by Media Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Media Type, 2017-2031 6.3.1. CHO Cell Media 6.3.2. Protein Expression Media 6.3.3. Immunology Media 6.3.4. Insect Cell Media 6.3.5. Hybridoma Media 6.3.6. Stem Cell Media 6.3.7. Chemically-defined Media 6.4. Market Attractiveness Analysis, by Media Type 7. Global Serum-free Media Market Analysis and Forecasts, By End-user 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by End-user, 2017–2031 7.3.1. Biopharma Industry 7.3.2. Clinical Research Organizations 7.3.3. Research Centers 7.3.4. Others 7.4. Market Attractiveness Analysis, by End-user 8. Global Serum-free Media Market Analysis and Forecasts, By Region 8.1. Key Findings 8.2. Market Value Forecast, by Region 8.2.1. North America 8.2.2. Europe 8.2.3. Asia Pacific 8.2.4. Latin America 8.2.5. Middle East & Africa 8.3. Market Attractiveness Analysis, by Region 9. North America Serum-free Media Market Analysis and Forecast 9.1. Introduction 9.1.1. Key Findings 9.2. Market Value Forecast, by Media Type, 2017–2031 9.2.1. CHO Cell Media 9.2.2. Protein Expression Media 9.2.3. Immunology Media 9.2.4. Insect Cell Media 9.2.5. Hybridoma Media 9.2.6. Stem Cell Media 9.2.7. Chemically-defined Media 9.3. Market Value Forecast, by End-user, 2017–2031 9.3.1. Biopharma Industry 9.3.2. Clinical Research Organizations 9.3.3. Research Centers 9.3.4. Others 9.4. Market Value Forecast, by Country, 2017–2031 9.4.1. U.S. 9.4.2. Canada 9.5. Market Attractiveness Analysis 9.5.1. By Media Type 9.5.2. By End-user 9.5.3. By Country 10. Europe Serum-free Media Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Media Type, 2017–2031 10.2.1. CHO Cell Media 10.2.2. Protein Expression Media 10.2.3. Immunology Media 10.2.4. Insect Cell Media 10.2.5. Hybridoma Media 10.2.6. Stem Cell Media 10.2.7. Chemically-defined Media 10.3. Market Value Forecast, by End-user, 2017–2031 10.3.1. Biopharma Industry 10.3.2. Clinical Research Organizations 10.3.3. Research Centers 10.3.4. Others 10.4. Market Value Forecast, by Country/Sub-region, 2017–2031 10.4.1. Germany 10.4.2. U.K. 10.4.3. France 10.4.4. Spain 10.4.5. Italy 10.4.6. Rest of Europe 10.5. Market Attractiveness Analysis 10.5.1. By Media Type 10.5.2. By End-user 10.5.3. By Country/Sub-region 11. Asia Pacific Serum-free Media Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Media Type, 2017–2031 11.2.1. CHO Cell Media 11.2.2. Protein Expression Media 11.2.3. Immunology Media 11.2.4. Insect Cell Media 11.2.5. Hybridoma Media 11.2.6. Stem Cell Media 11.2.7. Chemically-defined Media 11.3. Market Value Forecast, by End-user, 2017–2031 11.3.1. Biopharma Industry 11.3.2. Clinical Research Organizations 11.3.3. Research Centers 11.3.4. Others 11.4. Market Value Forecast, by Country/Sub-region, 2017–2031 11.4.1. China 11.4.2. Japan 11.4.3. India 11.4.4. Australia & New Zealand 11.4.5. Rest of Asia Pacific 11.5. Market Attractiveness Analysis 11.5.1. By Media Type 11.5.2. By End-user 11.5.3. By Country/Sub-region 12. Latin America Serum-free Media Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Media Type, 2017–2031 12.2.1. CHO Cell Media 12.2.2. Protein Expression Media 12.2.3. Immunology Media 12.2.4. Insect Cell Media 12.2.5. Hybridoma Media 12.2.6. Stem Cell Media 12.2.7. Chemically-defined Media 12.3. Market Value Forecast, by End-user, 2017–2031 12.3.1. Biopharma Industry 12.3.2. Clinical Research Organizations 12.3.3. Research Centers 12.3.4. Others 12.4. Market Value Forecast, by Country/Sub-region, 2017–2031 12.4.1. Brazil 12.4.2. Mexico 12.4.3. Rest of Latin America 12.5. Market Attractiveness Analysis 12.5.1. By Media Type 12.5.2. By End-user 12.5.3. By Country/Sub-region 13. Middle East & Africa Serum-free Media Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Media Type, 2017–2031 13.2.1. CHO Cell Media 13.2.2. Protein Expression Media 13.2.3. Immunology Media 13.2.4. Insect Cell Media 13.2.5. Hybridoma Media 13.2.6. Stem Cell Media 13.2.7. Chemically-defined Media 13.3. Market Value Forecast, by End-user, 2017–2031 13.3.1. Biopharma Industry 13.3.2. Clinical Research Organizations 13.3.3. Research Centers 13.3.4. Others 13.4. Market Value Forecast, by Country/Sub-region, 2017–2031 13.4.1. GCC Countries 13.4.2. South Africa 13.4.3. Rest of Middle East & Africa 13.5. Market Attractiveness Analysis 13.5.1. By Media Type 13.5.2. By End-user 13.5.3. By Country/Sub-region 14. Competition Landscape 14.1. Market Player – Competition Matrix (By Tier and Size of companies) 14.2. Market Share Analysis by Company (2020) 14.3. Company Profiles 14.3.1. Thermo Fisher Scientific 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.1.2. Product Portfolio 14.3.1.3. SWOT Analysis 14.3.1.4. Strategic Overview 14.3.2. Athena Environmental Sciences 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2.2. Product Portfolio 14.3.2.3. SWOT Analysis 14.3.2.4. Strategic Overview 14.3.3. Pan Biotech 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.3.2. Product Portfolio 14.3.3.3. SWOT Analysis 14.3.3.4. Strategic Overview 14.3.4. Sigma-Aldrich 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.4.2. Product Portfolio 14.3.4.3. SWOT Analysis 14.3.4.4. Strategic Overview 14.3.5. CellGenix 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.5.2. Product Portfolio 14.3.5.3. SWOT Analysis 14.3.5.4. Strategic Overview 14.3.6. HiMedia Laboratories 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.6.2. Product Portfolio 14.3.6.3. SWOT Analysis 14.3.6.4. Strategic Overview 14.3.7. Biological Industries 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.7.2. Product Portfolio 14.3.7.3. SWOT Analysis 14.3.7.4. Strategic Overview 14.3.8. Irvine Scientific 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.8.2. Product Portfolio 14.3.8.3. SWOT Analysis 14.3.8.4. Strategic Overview
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
Transparency Market Research社のその他分野での最新刊レポート
本レポートと同じKEY WORD(industry)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |